Background: There are few studies in the literature comparing the effectiveness of topical treatments in early-stage mycosis fungoides (MF).
Objectives: It was aimed to evaluate the clinical efficacy, side effects and topical treatment compliance with bexarotene or clobetasol propionate in early-stage MF.
Methods: A total of 40 patients with stage IA-IB MF were enrolled in the study.